KEYCORP /NEW/ (KEY-PJ) Insider Transactions
Explore official ownership filings, with every record linked to its source.
KEY-PJ · KEYCORP /NEW/
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-30Filed 2026-11-02 | Paine Andrew J IIIOfficer · Head of Institutional BankFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reported as of October 28, 2026. References: | G GiftCommon Shares · Non-derivative | 4,265D | 0 | IndirectBy spouse | Form 4 ↗0001669883-26-000005 |
| 2026-10-28Filed 2026-11-02Amendment | Paine Andrew J IIIOfficer · Head of Institutional BankFiling contextAmendment: compare with original; not an additional trade. F1 The Form 4 filed by the reporting person on October 29, 2026, inadvertently omitted an additional gift of shares effected on October 28, 2026. References: F1 | G GiftCommon Shares · Non-derivative | 7,555D | 0 | Direct | Form 4/A ↗0001669883-26-000004 |
| 2026-10-28Filed 2026-10-29 | Paine Andrew J IIIOfficer · Head of Institutional BankFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 On March 16, 2026, the reporting person contributed 50,630 directly owned shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. On April 23, 2026, 19,684 shares from a separate grantor retained annuity trust were returned to the reporting person as directly owned. Upon termination of a separate grantor retained annuity trust, 11,956 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and are reported in this Form 4 as directly owned. F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.21. F3 The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 Reported as of October 28, 2026. F5 This option vested in four equal annual installments ending on February 17, 2021. References: F5 | M Exercise / conversionOption to Buy · Derivative | 39,130D | 0 | Direct | Form 4 ↗0001669883-26-000003 |
| 2026-10-28Filed 2026-10-29 | Paine Andrew J IIIOfficer · Head of Institutional BankFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 On March 16, 2026, the reporting person contributed 50,630 directly owned shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. On April 23, 2026, 19,684 shares from a separate grantor retained annuity trust were returned to the reporting person as directly owned. Upon termination of a separate grantor retained annuity trust, 11,956 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and are reported in this Form 4 as directly owned. F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.21. F3 The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 Reported as of October 28, 2026. F5 This option vested in four equal annual installments ending on February 17, 2021. References: F2, F3 | S Sale (market/private)Common Shares · Non-derivative | 39,130D | 21.2 | Direct | Form 4 ↗0001669883-26-000003 |
| 2026-10-28Filed 2026-10-29 | Paine Andrew J IIIOfficer · Head of Institutional BankFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 On March 16, 2026, the reporting person contributed 50,630 directly owned shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. On April 23, 2026, 19,684 shares from a separate grantor retained annuity trust were returned to the reporting person as directly owned. Upon termination of a separate grantor retained annuity trust, 11,956 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and are reported in this Form 4 as directly owned. F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.21. F3 The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 Reported as of October 28, 2026. F5 This option vested in four equal annual installments ending on February 17, 2021. References: F1 | M Exercise / conversionCommon Shares · Non-derivative | 39,130A | 18.96 | Direct | Form 4 ↗0001669883-26-000003 |
| 2026-10-27Filed 2026-10-29 | Paine Andrew J IIIOfficer · Head of Institutional BankFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 On March 16, 2026, the reporting person contributed 50,630 directly owned shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. On April 23, 2026, 19,684 shares from a separate grantor retained annuity trust were returned to the reporting person as directly owned. Upon termination of a separate grantor retained annuity trust, 11,956 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and are reported in this Form 4 as directly owned. F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.21. F3 The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 Reported as of October 28, 2026. F5 This option vested in four equal annual installments ending on February 17, 2021. References: F1 | G GiftCommon Shares · Non-derivative | 11,956D | 0 | IndirectBy GRAT | Form 4 ↗0001669883-26-000003 |
| 2026-10-01Filed 2026-10-02 | Snyder Barbara RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan. F2 Includes approximately 133 common shares acquired through dividend reinvestments in September 2026. F3 Each deferred share is the economic equivalent of one common share. F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025. F5 Includes approximately 80 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in September 2026. F6 Includes approximately 1,417 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan in September 2026. References: F3, F6 | M Exercise / conversionDeferred Shares · Derivative | 1,417D | 0 | Direct | Form 4 ↗0001496583-26-000007 |
| 2026-10-01Filed 2026-10-02 | Snyder Barbara RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan. F2 Includes approximately 133 common shares acquired through dividend reinvestments in September 2026. F3 Each deferred share is the economic equivalent of one common share. F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025. F5 Includes approximately 80 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in September 2026. F6 Includes approximately 1,417 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan in September 2026. References: F1, F4, F5 | M Exercise / conversionDeferred Shares · Derivative | 1,526D | — | Direct | Form 4 ↗0001496583-26-000007 |
| 2026-10-01Filed 2026-10-02 | Snyder Barbara RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan. F2 Includes approximately 133 common shares acquired through dividend reinvestments in September 2026. F3 Each deferred share is the economic equivalent of one common share. F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025. F5 Includes approximately 80 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in September 2026. F6 Includes approximately 1,417 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan in September 2026. References: F3 | M Exercise / conversionCommon Shares · Non-derivative | 1,417A | — | Direct | Form 4 ↗0001496583-26-000007 |
| 2026-10-01Filed 2026-10-02 | Snyder Barbara RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan. F2 Includes approximately 133 common shares acquired through dividend reinvestments in September 2026. F3 Each deferred share is the economic equivalent of one common share. F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025. F5 Includes approximately 80 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in September 2026. F6 Includes approximately 1,417 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan in September 2026. References: F1, F2 | M Exercise / conversionCommon Shares · Non-derivative | 1,526A | — | Direct | Form 4 ↗0001496583-26-000007 |
| 2026-09-30Filed 2026-10-02 | Rankin Devina ADirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2029, or the death of the participant. F3 Includes approximately 862 dividend-equivalent deferred shares accrued under the Deferred Share Plan in September 2026. References: F1, F2, F3 | A Award / grantDeferred Shares · Derivative | 1,557A | 0 | Direct | Form 4 ↗0001557267-26-000006 |
| 2026-09-30Filed 2026-10-02 | Hayes RobinDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2030, or the death of the participant. F3 Includes approximately 498 dividend-equivalent deferred shares accrued under the Deferred Share Plan in September 2026. References: F1, F2, F3 | A Award / grantDeferred Shares · Derivative | 1,557A | 0 | Direct | Form 4 ↗0001443147-26-000007 |
| 2026-09-30Filed 2026-10-02 | VASOS TODD JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of July 1, 2028, or the death of the participant. F3 Includes approximately 478 dividend-equivalent deferred shares accrued under the Deferred Share Plan in September 2026. References: F1, F2, F3 | A Award / grantDeferred Shares · Derivative | 1,930A | 0 | Direct | Form 4 ↗0001243183-26-000006 |
| 2026-09-30Filed 2026-10-02 | CUTLER ALEXANDER MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Directors may elect to defer the payment of directors' fees into the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of July 1, 2027, or the death of the participant. F3 Includes approximately 374 dividend-equivalent deferred shares accrued under the Deferred Share Plan in September 2026. References: F1, F2, F3 | A Award / grantDeferred Shares · Derivative | 840A | 0 | Direct | Form 4 ↗0001188585-26-000006 |
| 2026-09-21Filed 2026-09-23 | Gorman Christopher M.Director · Officer · Chairman and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Upon termination of this grantor retained annuity trust on September 21, 2026, 29,821 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and continue to be reported in this Form 4 as directly owned. F2 Includes approximately 191 common shares acquired under the KeyCorp Second Amended and Restated Discounted Stock Purchase Plan since March 2026. F3 These shares are held in a grantor retained annuity trust for the benefit of the reporting person and the reporting person's children. The reporting person is the trustee of the trust. F4 Reported as of September 22, 2026. References: F1 | G GiftCommon Shares · Non-derivative | 29,821D | 0 | IndirectBy GRAT | Form 4 ↗0001486643-26-000002 |
| 2026-07-22Filed 2026-07-24 | Ramani MohitOfficer · Chief Risk OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Includes approximately 1,067 common shares acquired through dividend reinvestments between March and June 2026. References: F1 | S Sale (market/private)Common Shares · Non-derivative | 25,000D | 22.74 | Direct | Form 4 ↗0002053125-26-000003 |
| 2026-07-07Filed 2026-07-07 | BANK OF NOVA SCOTIADirector · Ten-percent ownerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Disposition pursuant to the Investment Agreement by and between the Reporting Person and the Issuer, dated August 12, 2024 (the "Investment Agreement"), and related arrangements between the Reporting Person and the Issuer, pursuant to which the Reporting Person participates (in certain circumstances, automatically), on a pro rata basis, in any repurchase by the Issuer of its common shares. Solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person may be deemed to be a director-by-deputization by virtue of the Reporting Person's contractual right to nominate directors to the board of directors of the Issuer pursuant to the Investment Agreement. References: F1 | D Other reported codeCommon Shares · Non-derivative | 176,803D | 23.18 | Direct | Form 4 ↗0000950157-26-000788 |
| 2026-07-01Filed 2026-07-06 | Snyder Barbara RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan. F2 Includes approximately 126 common shares acquired through dividend reinvestments in June 2026. F3 Each deferred share is the economic equivalent of one common share. F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025. F5 Includes approximately 82 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in June 2026. F6 Includes approximately 1,542 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2026 Equity Compensation Plan in June 2026. References: F3, F6 | M Exercise / conversionDeferred Shares · Derivative | 20,168D | 0 | Direct | Form 4 ↗0001496583-26-000006 |
| 2026-07-01Filed 2026-07-06 | Snyder Barbara RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan. F2 Includes approximately 126 common shares acquired through dividend reinvestments in June 2026. F3 Each deferred share is the economic equivalent of one common share. F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025. F5 Includes approximately 82 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in June 2026. F6 Includes approximately 1,542 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2026 Equity Compensation Plan in June 2026. References: F1, F4, F5 | M Exercise / conversionDeferred Shares · Derivative | 1,526D | — | Direct | Form 4 ↗0001496583-26-000006 |
| 2026-07-01Filed 2026-07-06 | Snyder Barbara RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan. F2 Includes approximately 126 common shares acquired through dividend reinvestments in June 2026. F3 Each deferred share is the economic equivalent of one common share. F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025. F5 Includes approximately 82 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in June 2026. F6 Includes approximately 1,542 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2026 Equity Compensation Plan in June 2026. References: F3 | M Exercise / conversionCommon Shares · Non-derivative | 20,168A | — | Direct | Form 4 ↗0001496583-26-000006 |
| 2026-07-01Filed 2026-07-06 | Snyder Barbara RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan. F2 Includes approximately 126 common shares acquired through dividend reinvestments in June 2026. F3 Each deferred share is the economic equivalent of one common share. F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025. F5 Includes approximately 82 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in June 2026. F6 Includes approximately 1,542 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2026 Equity Compensation Plan in June 2026. References: F1, F2 | M Exercise / conversionCommon Shares · Non-derivative | 1,526A | — | Direct | Form 4 ↗0001496583-26-000006 |
| 2026-07-01Filed 2026-07-06 | VASOS TODD JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each deferred share is the economic equivalent of one common share. References: F1 | M Exercise / conversionDeferred Shares · Derivative | 27,385D | 0 | Direct | Form 4 ↗0001243183-26-000005 |
| 2026-07-01Filed 2026-07-06 | VASOS TODD JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each deferred share is the economic equivalent of one common share. References: F1 | M Exercise / conversionCommon Shares · Non-derivative | 27,385A | — | Direct | Form 4 ↗0001243183-26-000005 |
| 2026-07-01Filed 2026-07-06 | CUTLER ALEXANDER MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each deferred share is the economic equivalent of one common share. References: F1 | M Exercise / conversionDeferred Shares · Derivative | 26,893D | 0 | Direct | Form 4 ↗0001188585-26-000005 |
| 2026-07-01Filed 2026-07-06 | CUTLER ALEXANDER MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each deferred share is the economic equivalent of one common share. References: F1 | M Exercise / conversionCommon Shares · Non-derivative | 26,893A | — | Direct | Form 4 ↗0001188585-26-000005 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.